Equities

Angle PLC

Angle PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)13.75
  • Today's Change-0.50 / -3.51%
  • Shares traded715.86k
  • 1 Year change+8.02%
  • Beta1.0111
Data delayed at least 20 minutes, as of Jul 04 2024 17:07 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.

  • Revenue in GBP (TTM)2.19m
  • Net income in GBP-20.13m
  • Incorporated2003
  • Employees150.00
  • Location
    Angle PLCThe Surrey Research Park, 10 Nugent RoadGUILDFORD GU2 7AFUnited KingdomGBR
  • Phone+44 148 334 3434
  • Fax+44 148 368 5836
  • Websitehttps://www.angleplc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Proteome Sciences plc5.03m-2.44m11.07m35.00------2.20-0.0083-0.00830.017-0.01040.42093.893.04143,657.10-20.45-1.22----32.7654.53-48.59-2.200.2667-2.031.29---35.3710.52-284.38--126.22--
Inspiration Healthcare Group PLC37.63m-6.32m11.94m210.00--0.4122--0.3173-0.0925-0.09250.55160.42450.72431.673.66---12.170.8965-14.861.1047.5347.61-16.800.99220.9698-0.91720.307---8.7419.43-2,423.90--31.88--
Genincode PLC2.16m-7.02m11.95m36.00--5.02--5.53-0.0732-0.07320.02250.01350.270321.883.3360,000.00-87.79---124.10--47.31---324.81--1.24--0.1883--51.05---26.21------
Abingdon Health PLC5.34m-2.24m12.99m82.00--6.88--2.43-0.0184-0.01840.04390.01490.89787.674.7465,170.73-37.55-51.31-58.04-79.8557.3533.16-41.82-139.641.59--0.3572--42.68--83.77------
Verici DX PLC795.13k-6.86m15.77m14.00--3.96--19.83-0.0403-0.04030.00470.01640.0932--1.5956,795.29-80.32---115.94--1.58---862.19------0.0438------23.43------
Renalytix PLC2.67m-36.28m16.98m80.00--0.7122--6.36-0.4441-0.44410.03250.15450.06462.884.0633,388.96-87.73-58.25-120.00-67.0320.60---1,358.30-1,904.791.71-9.620.397--14.58--18.52------
Polarean Imaging PLC699.32k-9.33m20.82m29.00--0.6701--29.77-0.0372-0.03720.00280.02570.05330.28240.759924,114.40-71.12-61.45-81.95-69.1737.6650.68-1,333.98-810.923.11--0.0255---13.75-18.2414.53--64.51--
Ondine Biomedical Inc692.38k-8.29m21.45m43.00--14.62--30.99-0.0421-0.04210.00350.00530.10790.42374.74---129.24---193.37--58.44---1,198.01--1.06--0.206--88.56--25.60------
Belluscura PLC647.89k-14.54m24.94m24.00--1.48--38.50-0.1101-0.11010.0050.1010.03720.21180.1975---83.37-49.84-96.68-54.78-50.80-37.48-2,243.45-1,277.341.71-4.07-----40.9627.44-127.13--41.32--
ANGLE plc2.19m-20.13m45.98m150.00--1.62--21.03-0.0772-0.07720.00840.08790.05390.35211.2114,573.33-49.68---56.03--69.90---920.95--4.95--0.1656--109.99--7.17------
Tissue Regenix Group PLC23.15m-1.34m46.91m76.00--1.96--2.03-0.0191-0.01910.32870.33530.66071.466.91304,604.50-3.71-13.45-4.17-14.7847.6045.90-5.62-28.801.84-0.3090.2425--20.5013.7536.44--9.78--
Inspecs Group PLC203.29m-997.00k55.41m1.67k--0.53534.600.2726-0.0109-0.01091.941.020.88642.248.68121,513.40-0.4347-1.48-0.6975-2.1550.9448.50-0.4904-1.970.86771.540.375--1.1636.4584.22--51.04--
SDI Group PLC68.07m1.61m66.91m489.0042.161.5311.340.9830.01520.01520.65280.41740.79582.086.29139,206.501.938.832.3411.4363.3464.572.4310.641.145.860.33110.0036.0936.05-48.6819.1111.86--
Data as of Jul 04 2024. Currency figures normalised to Angle PLC's reporting currency: UK Pound GBX

Institutional shareholders

23.48%Per cent of shares held by top holders
HolderShares% Held
Global Frontier Investments LLCas of 08 Feb 202416.87m6.47%
Hargreaves Lansdown Asset Management Ltd.as of 01 May 20249.82m3.77%
Baillie Gifford & Co.as of 23 Jun 20238.05m3.09%
Chelverton Asset Management Ltd.as of 30 Jun 20237.50m2.88%
Aegon Asset Management UK PLCas of 06 Jan 20245.29m2.03%
IG Markets Ltd.as of 01 May 20243.41m1.31%
Evelyn Partners Investment Management LLPas of 01 May 20243.25m1.25%
Unicorn Asset Management Ltd.as of 01 May 20242.77m1.06%
Canaccord Genuity Wealth Ltd.as of 30 Sep 20232.18m0.84%
United Nations Joint Staff Pension Fundas of 01 May 20242.04m0.78%
More ▼
Data from 30 Sep 2023 - 03 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.